⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
TEZSPIRE® (tezepelumab
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. TEZSPIRE® (tezepelumab just got measured.
6/10 means TEZSPIRE® (tezepelumab is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
About TEZSPIRE® (tezepelumab
TEZSPIRE is an add-on medication to treat patients 12 and older with severe asthma and adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Learn more about TEZSPIRE treatment depending on the condition.
Key Topics
Details
Industry: Healthcare
tezspire.comAI Visibility Breakdown
1
Structured Data
8
Content Structure
6
Entity Clarity
5
E-E-A-T Signals
8
Technical AEO
7
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for TEZSPIRE® (tezepelumab.
Source & Attribution
Scored by Engagemii on July 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/tezspire
Cite this score: Engagemii (2026). "AEO Score for TEZSPIRE® (tezepelumab." Retrieved from https://engagemii.com/aeo/brands/tezspire
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform